Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Clinicopathological significance of GADD45 gene alterations in human familial breast carcinoma.

Sensi E, Tancredi M, Aretini P, Cipollini G, Collecchi P, Naccarato AG, Viacava P, Bevilacqua G, Caligo MA.

Breast Cancer Res Treat. 2004 Sep;87(2):197-201.

PMID:
15377844
2.

Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.

Rhiem K, Todt U, Wappenschmidt B, Klein A, Wardelmann E, Schmutzler RK.

Anticancer Res. 2010 Sep;30(9):3445-9.

PMID:
20944121
3.

Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer.

Yamasawa K, Nio Y, Dong M, Yamaguchi K, Itakura M.

Clin Cancer Res. 2002 Aug;8(8):2563-9.

4.

Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.

Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC.

Breast Cancer Res Treat. 2004 Nov;88(2):177-86.

PMID:
15564800
5.

Induction of the p53-target gene GADD45 in HPV-positive cancer cells.

Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F.

Oncogene. 1999 Apr 8;18(14):2381-6.

6.

Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.

Gras E, Cortes J, Diez O, Alonso C, Matias-Guiu X, Baiget M, Prat J.

Cancer. 2001 Aug 15;92(4):787-95.

PMID:
11550149
7.

Loss of heterozygosity in bilateral breast cancer.

Kollias J, Man S, Marafie M, Carpenter K, Pinder S, Ellis IO, Blamey RW, Cross G, Brook JD.

Breast Cancer Res Treat. 2000 Dec;64(3):241-51.

PMID:
11200774
8.

Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.

Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T, Eng C.

Am J Hum Genet. 2006 Jun;78(6):961-72. Epub 2006 Apr 12.

9.

Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.

Kannan K, Krishnamurthy J, Feng J, Nakajima T, Tsuchida N, Shanmugam G.

Int J Oncol. 2000 Nov;17(5):1031-5.

PMID:
11029509
10.

The GADD45, ZBRK1 and BRCA1 pathway: quantitative analysis of mRNA expression in colon carcinomas.

Garcia V, García JM, Peña C, Silva J, Domínguez G, Rodríguez R, Maximiano C, Espinosa R, España P, Bonilla F.

J Pathol. 2005 May;206(1):92-9.

PMID:
15772983
11.

Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.

Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.

Hum Mutat. 2005 Mar;25(3):319.

PMID:
15712267
12.

Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.

Cao AY, Jin W, Shi PC, Di GH, Shen ZZ, Shao ZM.

Breast Cancer Res Treat. 2010 Jan;119(2):295-303. doi: 10.1007/s10549-009-0349-6. Epub 2009 Feb 24.

PMID:
19238535
13.

BRCA1 activation of the GADD45 promoter.

Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace AJ Jr, Zhan Q.

Oncogene. 2000 Aug 17;19(35):4050-7.

PMID:
10962562
14.

Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437.

Rishi AK, Sun RJ, Gao Y, Hsu CK, Gerald TM, Sheikh MS, Dawson MI, Reichert U, Shroot B, Fornace AJ Jr, Brewer G, Fontana JA.

Nucleic Acids Res. 1999 Aug 1;27(15):3111-9.

15.

Gadd45 mutations are uncommon in human tumour cell lines.

Campomenosi P, Hall PA.

Cell Prolif. 2000 Oct;33(5):301-6.

PMID:
11063132
16.

Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.

Choi DH, Lee MH, Bale AE, Carter D, Haffty BG.

J Clin Oncol. 2004 May 1;22(9):1638-45.

PMID:
15117986
17.

Low frequency of E-cadherin alterations in familial breast cancer.

Salahshor S, Haixin L, Huo H, Kristensen VN, Loman N, Sjöberg-Margolin S, Borg A, Børresen-Dale AL, Vorechovsky I, Lindblom A.

Breast Cancer Res. 2001;3(3):199-207. Epub 2001 Mar 9.

18.
19.

Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

King TA, Li W, Brogi E, Yee CJ, Gemignani ML, Olvera N, Levine DA, Norton L, Robson ME, Offit K, Borgen PI, Boyd J.

Ann Surg Oncol. 2007 Sep;14(9):2510-8. Epub 2007 Jun 29.

PMID:
17597348
20.

Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.

Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P, Alomo I, Rajasekaran B, Zhan Q.

Oncogene. 2001 May 10;20(21):2683-90.

Supplemental Content

Support Center